Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06872775

855303-RNA Biomarker Validation

A Multi-Center Observational Study to Validate RNA-Biomarkers as Prognostic of Fracture Healing

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the accuracy of using RNA in blood as a way to forecast new fracture healing outcome.

Detailed description

This study will follow a registry + biospecimen collection format. Subjects will be enrolled at participating Sites as they present for care for new traumatic appendicular skeletal fractures (0 - ≤7 Days post-injury) and will provide blood specimens for study analysis and future use at up to 4 post-injury windows of treatment (i.e., Window 1, 0 - ≤7 Days; Window 2, 8 - ≤14 days; Window 3, 15 - ≤42 Days; and Window 4, 43 - ≤84 Days post-injury).

Conditions

Interventions

TypeNameDescription
OTHERBlood draws to assess RNA expression levelsNone. Standard of Care (SOC) only.

Timeline

Start date
2025-08-25
Primary completion
2028-08-24
Completion
2028-08-24
First posted
2025-03-12
Last updated
2026-01-16

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06872775. Inclusion in this directory is not an endorsement.

855303-RNA Biomarker Validation (NCT06872775) · Clinical Trials Directory